Artificial intelligence and space are undoubtedly the hottest sectors right now, but one industry far larger than both combined — healthcare — is quietly nurturing new winners. So far this year, a little-known health insurance company, Oscar Health (NYSE: OSCR), has seen its stock price rise 90% to a market cap of $8.6 billion. What’s more notable is that many analysts believe this rally is far from over.
Disrupting Traditional Health Insurance with a Focus on Experience
Oscar Health was founded in 2012 with the original intention of taking advantage of the Affordable Care Act (ACA) health insurance marketplace. Unlike traditional health insurers, it focused from the beginning on individual enrollees, significantly improving the user experience through services such as free telehealth, dedicated online customer service representatives, and modern digital tools. Many Americans have long held grievances against traditional health insurance companies, but Oscar, with its higher customer satisfaction ratings, has been steadily gaining market share in the ACA marketplace. By the end of last quarter, it had 3.2 million customers, making it one of the largest players in this space.
A Profit Inflection Point Has Arrived, with Earnings Beating Expectations
Historically, Oscar Health had not achieved consistent profitability, mainly due to the huge upfront investment required to build a health insurance network covering all 50 states. Now, with its customer base exceeding the million mark, fixed costs have been effectively diluted, and the company has finally entered a profit release phase.
For 2026, the company’s guidance sets a high end of $19 billion in revenue and $450 million in operating income, both records for the company. Notably, in the first quarter alone, it reported $700 million in operating income — already exceeding the full-year guidance total. Of course, due to healthcare utilization typically being lower in the first quarter and rising throughout the year, combined with some enrollees dropping monthly payments as the year progresses, the company expects to lose money over the next three quarters. Even so, it still expects to meet or exceed its full-year profit guidance. This “earnings surprise” has been the driving force behind the stock’s strong rally this year.
Vast Opportunity, Still Attractively Valued
The U.S. health insurance market is measured in trillions of dollars, yet Oscar currently has only 3.2 million customers — a very low penetration rate. Assuming it doubles its customer base to 6.5 million over the next five years (just a few years ago, total customers were under 1 million, so this assumption is not unreasonable), its premium revenue could grow from this year’s $19 billion to $50 billion. Even with a modest 5% operating margin, that would translate into $2.5 billion in annual operating income.
Currently, Oscar Health has a market cap of just $8.6 billion, or roughly 3.5 times its potential annual profit a few years from now. For a disruptor still rapidly grabbing market share, this valuation is far from expensive.
Conclusion
Oscar Health proves that in a massive, traditional industry full of pain points, improving the customer experience is itself a wide moat. This year’s 90% gain may deter some, but the company’s profit inflection point has just been confirmed, and its potential market remains vast. For investors who can hold for the long term, this dark horse in the healthcare sector may have only just begun to run.
